3353 — Medical Ikkou Co Income Statement
0.000.00%
- ¥10bn
- ¥13bn
- ¥40bn
- 83
- 89
- 61
- 94
Annual income statement for Medical Ikkou Co, fiscal year end - February 29th, JPY millions except per share, conversion factor applied.
2020 February 29th | R2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32,042 | 31,604 | 33,596 | 33,898 | 39,901 |
Cost of Revenue | |||||
Gross Profit | 3,440 | 3,203 | 3,615 | 3,183 | 4,552 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30,868 | 30,659 | 32,345 | 32,933 | 38,553 |
Operating Profit | 1,174 | 945 | 1,251 | 965 | 1,348 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,273 | 1,442 | 1,476 | 1,314 | 1,663 |
Provision for Income Taxes | |||||
Net Income After Taxes | 802 | 835 | 869 | 773 | 1,082 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 802 | 835 | 852 | 760 | 1,040 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 802 | 835 | 852 | 760 | 1,040 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 264 | 289 | 291 | 250 | 359 |
Dividends per Share | |||||
Special Dividends per Share |